Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma

Diagnostic Cytopathology

Volumn 29, Issue 4, 2003, Pages 194-199

  Pinto, António E ^a   Cabeçadas, José ^b   Nóbrega, Sónia D ^b   Mendonça, Evelina ^b  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b NONE

Author keywords

DNA ploidy; Fine needle aspiration cytology; Non Hodgkin's lymphoma; Prognosis; S phase fraction

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BIOPSY, FINE-NEEDLE; CELL DIVISION; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; S PHASE; SURVIVAL RATE;

EID: 0141481946     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10298     Document Type: Article

References (31)

1. Sneige N, Dekmezian RH, Katz RL, Fanning TV, Lukeman JL, Ordonez NF, Cabanillas FF. Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia. Acta Cytol 1990;34:311-322.
2. Ravinsky E, Morales C, Kutryk E, Chrobak A, Paraskevas F. Cytodiagnosis of lymphoid proliferations by fine needle aspiration biopsy: adjunctive value of flow cytometry. Acta Cytol 1999;43:1070-1078.
3. Young NA, Al-Saleem TI, Ehya H, Smith MR. Utilization of fine-needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma. Cancer (Cancer Cytopathol) 1998;84:252-261.
4. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
5. Stansfeld A, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, van Unnik JA, Mioduszewska O, Wright DH. Updated Kiel classification for lymphomas. Lancet 1988;1:292-293.
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
7. Christensson B, Tribukait B, Linder I-L, Ullman B, Biberfeld P. Cell proliferation and DNA content in non-Hodgkin's lymphoma: flow cytometry in relation to lymphoma classification. Cancer 1986;58:1295-1304.
8. Lehtinen T, Aine R, Lehtinen M, Kallioniemi O-P, Leino T, Hakala T, Leinikki P, Alavaikko M. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. J Pathol 1989;157:27-36.
9. Macartney JC, Camplejohn RS. DNA flow cytometry of non-Hodgkin's lymphomas. Eur J Cancer 1990;26:635-637.
10. Grierson HL, Wooldridge TN, Purtilo DT, Pierson J, Bast M, Wooldridge L, Armitage JO, Weisenburger DD. Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma. Cancer Res 1990;50:4845-4848.
11. Rehn S, Glimelius B, Strang P, Sundström C, Tribukait B. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol 1990;8:1-12.
12. Joensuu H, Klemi PJ, Soderstrom KO, Jalkanen S. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer 1991;68:1564-1571.
13. 3H-thymidine labeling index and flow-cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma. Br J Cancer 1992;66:680-684.
14. Duque RE, Andreeff M, Braylan RC, Diamond LW, Peiper SC. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 1993;14:492-496.
15. Stokke T, Smeland EB, Kvaløy S, Holte H. Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas. Br J Cancer 1998;77:1839-1841.
16. Deitch AD, Law H, White RD. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 1982;30:967-972.
17. Dean PN, Jett JH. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60:523-527.
18. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-477.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
21. Braylan RC, Benson NA, Nourse VA. Cellular DNA of human neoplastic B-cells measured by flow cytometry. Cancer Res 1984;44:5010-5016.
22. Chilosi M, Pizzolo G. Review of terminal deoxynucleotidyl transferase: biological aspects, methods of detection, and selected diagnostic applications. Appl Immunohistochem 1995;3:209-221.
23. Cowan RA, Harris M, Jones M, Crowther D. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br J Cancer 1989;60:904-910.
24. Christensson B, Lindemalm C, Johansson B, Mellstedt H, Tribukait B, Biberfeld P. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res 1989;13:307-314.
25. Morgan DR, Williamson JMS, Quirke P, Clayden AD, Smith MEF, O'Brien CJ, Allison DL, Child JA, Bird CC. DNA content and prognosis of non-Hodgkin's lymphoma. Br J Cancer 1986;54:643-649.
26. Saikia UN, Dey P, Vohra H, Gupta SK. DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse. Diagn Cytopathol 2000;22:152-156.
27. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 1985;66:1414-1422.
28. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, Pollice AA. Model for the genetic evolution of human solid tumors. Cancer Res 1989;49:3344-3354.
29. Lakkala T, Laasonen A, Franssila KO, Teerenhovi L, Knuutila S. Comparison of DNA and karyotype aneuploidy in malignant lymphomas. Am J Clin Pathol 1990;94:600-605.
30. Knowles DM. Neoplastic hematopathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p 691-753.
31. Sneige N, Dekmezian R, el-Naggar A, Manning J. Cytomorphologic, immunocytochemical, and nucleic acid flow cytometric study of 50 lymph nodes by fine-needle aspiration. Comparison with results obtained by subsequent excisional biopsy. Cancer 1991;67:1003-1007.